This study looks at how well a combination of three drugs—**gemcitabine, cisplatin, and nab-paclitaxel**—works when given before surgery for *pancreatic cancer*, which is a type of cancer that affects the pancreas, an organ that helps with digestion. These drugs are used to help shrink the tumor so it can be removed more easily during surgery. **Gemcitabine** stops cancer cells from making DNA. **Cisplatin** belongs to a group of drugs with platinum that can kill cancer cells. **Nab-paclitaxel** helps stop cancer cells from growing and dividing. If you join this study, you'll receive these drugs through an IV (a tube that goes into your vein) every two weeks, for up to four cycles. Afterward, doctors will perform surgery to remove the tumor if it's safe. The study will follow you for up to 24 months after treatment.
- Study Duration: Up to 24 months with regular follow-ups every 3-4 months.
- Visits Required: Multiple visits for drug administration and follow-up tests.
- Eligibility: Adults over 18 with specific types of pancreatic cancer.
How understandable was the trial content above?
Hard to understand
Easy to understand